CD4 and neoplasm: The favourable effect of tumour-infiltrating lymphocytes (TILs) on patient outcome is well established in CRC, whose immunogenicity has been demonstrated by the tumour-selective activation of CD8+ and the migration of CD4+ T helper cells [6].